frank - Frank Prado 1 English 100 Prince Ogunfeyimi...

Info iconThis preview shows pages 1–3. Sign up to view the full content.

View Full Document Right Arrow Icon
Frank Prado Prado, 1 English 100 Prince Ogunfeyimi Portfolio 3: Final Draft The Benefits of Psychedelic Drugs In the United States of America, psychedelic drugs such as lysergic acid diethylamide (LSD) and psilocybin mushrooms, are condemned as illegal, Schedule 1 controlled substances. In 1970, Congress declared a controlled substances act, which states that all drugs with schedule 1 classification meet the requirements of: 1. Serving no medical purpose, 2. Having a high potential for abuse, and 3. Possessing a lack of safety for use of the drug under medical supervision (FDA: Controlled Substances Act). Other schedule 1 substances may properly satisfy these three conditions, but the American government has categorized LSD and psilocybin incorrectly. Scientific research supports the notion that these psychedelic drugs do not meet any of these so-called classification requirements. One way this is achieved is through the very recent discovery of LSD and psilocybin having neurobiological implications that strongly suggest that they can benefit those suffering from mood disorders. It is also important to mention that these neurobiological findings also indicate the possibility of enhanced potential for neuroplasticity in all humans. Realizing the possibilities and strong indicators for enhanced medical treatment, one can realize that the schedule 1 legality of these substances hinders the gain of scientific knowledge in the area of psychedelics, especially because the classification makes it terribly difficult and almost impossible for American researchers to gain permission or access to a study involving human subjects with psychedelic drugs (Vollenweider, 642). The schedule 1 classification also puts these drugs in the same category as heroin, and a more severe classification than cocaine (schedule 2). This type of classification instills
Background image of page 1

Info iconThis preview has intentionally blurred sections. Sign up to view the full version.

View Full DocumentRight Arrow Icon
Prado,2 negative connotations into the citizens of America in respect to psychedelic drugs. Elementary textbooks and health related websites also portray incomplete and negative information pertaining to these drugs, which adds to the American public’s adverse opinion of the drugs. In this age of knowledge, it is time for the United States to change the schedule classification of LSD and psilocybin, so scientific advancements and improved medical treatment can become a reality. It is pertinent to understand how LSD and psilocybin interact with the human brain in order for one to have a better understanding of the drugs. Like alcohol, cigarettes, and prescription drugs, LSD and psilocybin are chemical compounds that work on a person’s central nervous system to alter the brain and other bodily functions. The understanding of how LSD and psilocybin affect the neurobiology of a human brain provides the logical reasoning for why these drugs should not be labeled as schedule 1 substances. With this in mind, LSD and psilocybin have the power to alter one’s state of mind by binding to multiple types of neurotransmitters
Background image of page 2
Image of page 3
This is the end of the preview. Sign up to access the rest of the document.

This document was uploaded on 10/25/2011 for the course WRD 104 at DePaul.

Page1 / 13

frank - Frank Prado 1 English 100 Prince Ogunfeyimi...

This preview shows document pages 1 - 3. Sign up to view the full document.

View Full Document Right Arrow Icon
Ask a homework question - tutors are online